<DOC>
	<DOCNO>NCT00768430</DOCNO>
	<brief_summary>Existing treatment major depressive disorder ( MDD ) generally take week month exert maximal benefit . There urgent need develop rapid-acting treatment MDD . Ketamine , high-affinity N-methyl-D-aspartate ( NMDA ) glutamate receptor antagonist , use standard intravenous ( IV ) anesthetic agent many year pediatric adult patient . Beyond well-established role anesthesia pain management , emerge evidence ketamine may rapid antidepressant property patient severe mood disorder . In study investigate whether ketamine antidepressant effect compare midazolam . Midazolam similar anesthetic effect compare ketamine show antidepressant , therefore act active control study . The study period last 8 week , depend response study medication . There two require overnight stay Research Commons part study .</brief_summary>
	<brief_title>Optimization IV Ketamine Treatment Resistant Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>1 . Male female patient , 2180 year age ; 2 . Female individual childbearing potential ( i.e. , surgically sterile , postmenopausal least one year ) use medically accept reliable mean contraception . Women use oral contraceptive medication birth control must also use barrier contraceptive . Women childbearing potential must also negative serum betahuman growth hormone screen preinfusion ; 3 . Participants must fulfill DSMIV criterion Major Depression without psychotic feature , base clinical assessment study psychiatrist confirm structured diagnostic interview , Structured Clinical Interview DSMIV TR Axis I Disorders , Patient Edition ( SCIDP ) ; 4 . Participants must history least one previous episode depression prior current episode ( recurrent MDD ) chronic MDD ( least two year ' duration ) ; 5 . Participants respond three adequate trial antidepressant determine Antidepressant Treatment History Form ( ATHF ) criterion ( score &gt; =3 ) ; 6 . Participant score IDSC30 must great equal 32 Screening within 24 hour prior Visit 1a ( Phase 1 ) ; 7 . Current major depressive episode least 4 week duration . 8 . Each participant must level understanding sufficient agree test examination require protocol must sign informed consent document ; 9 . Each participant must able identify family member , physician , friend participate Treatment Contract . 1 . Lifetime history psychotic feature , diagnosis schizophrenia psychotic disorder , diagnosis bipolar disorder 2 . Lifetime histories autism , mental retardation , pervasive developmental disorder , Tourette 's syndrome ; 3 . Current diagnosis Obsessive Compulsive Disorder eat disorder ( bulimia nervosa anorexia nervosa ) ; 4 . Subjects DSMIV drug alcohol abuse/dependence within precede 2 year ; 5 . Patients schizotypal antisocial personality disorder , clinically significant axis II disorder would , investigator 's judgment , preclude safe study participation ; 6 . Patients judge clinically serious imminent suicidal homicidal risk ; 7 . Women either pregnant nursing ; 8 . Serious , unstable medical illness include hepatic , renal , gastroenterologic ( include gastroesophageal reflux disease ) , respiratory ( include obstructive sleep apnea , history difficulty airway management previous anesthetic ) , cardiovascular ( include ischemic heart disease uncontrolled hypertension ) , endocrinologic , neurologic ( include history severe head injury ) , immunologic , hematologic disease ; 9 . Clinically significant abnormal finding laboratory parameter , physical examination , ECG ; 10 . Patients one seizures without clear resolve etiology ; 11 . Patients start hormonal treatment ( e.g. , estrogen ) last 3 month prior Visit 1a ; 12 . Treatment irreversible MAOI FDA approve Anti depressant medication within one week prior Visit 1a ( exception stable dose nonbenzodiazepines hypnotic i.e . zolpidem , eszopiclone , etc least 3 month ) ; 13 . Treatment fluoxetine within 4 week prior Visit 1a ; 14 . Evidencebased individual psychotherapy ( e.g . CBT IPT ) nonpharmacological antidepressant treatment ( e.g . light therapy ) permit acute study period ( 7 day ) ; 15 . Previous recreational use PCP Ketamine . 16 . Past intolerance hypersensitivity midazolam 17 . Hypertension ( systolic BP &gt; 160 mm Hg diastolic BP &gt; 90 mm Hg ) control diuretic betablocker therapy alone combination . 18 . Evidence agerelated cognitive decline mild dementia suggest score &lt; 27 MiniMental State Examination ( MMSE ) Screening</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>